Clinical effects of intravenous iloprost in patients with intermittent claudication
- PMID: 2446877
- DOI: 10.1007/BF00544555
Clinical effects of intravenous iloprost in patients with intermittent claudication
Abstract
In a randomized patient-blind study iloprost or hydroxy-ethyl starch 200/0.5 were given i.v. 5 h daily for 2 weeks to 24 patients suffering from severe intermittent claudication due to peripheral vascular disease. An increase in pain-free walking distance of more than 50% occurred in 6 of 11 patients after the iloprost infusions and in 7 of 12 patients after HES treatment. No significant effects on haemodynamic or clinical chemistry tests were observed.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
